Southpoint Capital Advisors LP Acquires 600,000 Shares of Option Care Health, Inc. $OPCH

Southpoint Capital Advisors LP grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 20.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,600,000 shares of the company’s stock after acquiring an additional 600,000 shares during the quarter. Option Care Health accounts for approximately 2.0% of Southpoint Capital Advisors LP’s holdings, making the stock its 23rd biggest holding. Southpoint Capital Advisors LP’s holdings in Option Care Health were worth $96,912,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. V Square Quantitative Management LLC purchased a new stake in shares of Option Care Health in the 4th quarter valued at $25,000. Advisory Services Network LLC bought a new stake in Option Care Health in the third quarter worth $35,000. McIlrath & Eck LLC bought a new stake in Option Care Health in the second quarter worth $37,000. Caitong International Asset Management Co. Ltd purchased a new stake in Option Care Health during the third quarter valued at about $38,000. Finally, Quarry LP boosted its position in Option Care Health by 502.7% during the third quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after buying an additional 1,292 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Trading Up 0.7%

NASDAQ OPCH opened at $21.81 on Tuesday. Option Care Health, Inc. has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64. The stock has a 50 day simple moving average of $21.36 and a two-hundred day simple moving average of $27.01. The stock has a market cap of $3.42 billion, a P/E ratio of 16.91, a price-to-earnings-growth ratio of 1.20 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.39 billion. During the same period in the previous year, the firm earned $0.40 earnings per share. The business’s revenue was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, analysts forecast that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Insider Activity at Option Care Health

In related news, CEO John Charles Rademacher acquired 12,500 shares of Option Care Health stock in a transaction on Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the transaction, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy P. Sullivan acquired 24,154 shares of the firm’s stock in a transaction on Thursday, May 7th. The stock was bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the completion of the acquisition, the director directly owned 73,383 shares in the company, valued at approximately $1,518,294.27. This represents a 49.06% increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 73,264 shares of company stock worth $1,548,316 over the last quarter. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on OPCH. JPMorgan Chase & Co. decreased their price objective on Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. The Goldman Sachs Group began coverage on Option Care Health in a report on Monday, June 8th. They set a “neutral” rating and a $22.00 target price for the company. UBS Group restated a “buy” rating on shares of Option Care Health in a research report on Tuesday, June 16th. Weiss Ratings cut Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday. Finally, Barrington Research lowered their price objective on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $30.08.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.